Literature DB >> 7535621

Role of T cell DNA methylation in lupus syndromes.

R L Yung, B C Richardson.   

Abstract

Current theories postulate that exposure to certain environmental agents will induce lupus in genetically predisposed individuals. However, the mechanisms by which environmental agents interact with the immune system to trigger lupus is unclear. Recent work has shown that some environmental agents associated with lupus, such as procainamide, hydralazine and ultraviolet light, will inhibit T cell DNA methylation, increase LFA-1 expression and induce autoreactivity. In addition, T cells isolated from patients with active lupus have hypomethlated DNA, diminished DNA methyltransferase activity and overexpress LFA-1 on an autoreactive subset of cells which spontaneously lyses autologous macrophages. More recent work has shown that the adoptive transfer of murine T cells made autoreactive with DNA methylation inhibitors is sufficient to cause a lupus-like disease in otherwise healthy syngeneic recipients. Together, these results support a new model of autoimmunity, in which certain environmental agents modify T cells by inhibiting DNA methylation and altering expression of certain genes, thereby inducing autoreactivity. The autoreactive cells then interact with the host to produce a lupus-like disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7535621     DOI: 10.1177/096120339400300611

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  15 in total

1.  The implications of DNA methylation for toxicology: toward toxicomethylomics, the toxicology of DNA methylation.

Authors:  Moshe Szyf
Journal:  Toxicol Sci       Date:  2011-02-04       Impact factor: 4.849

2.  High salt diet accelerates the progression of murine lupus through dendritic cells via the p38 MAPK and STAT1 signaling pathways.

Authors:  Ze Xiu Xiao; Xiaojiang Hu; Ximei Zhang; Zhigang Chen; Julie Wang; Ke Jin; Feng Lin Cao; Baoqing Sun; Joseph A Bellanti; Nancy Olsen; Song Guo Zheng
Journal:  Signal Transduct Target Ther       Date:  2020-04-10

Review 3.  Inhibitory oligodeoxynucleotides - therapeutic promise for systemic autoimmune diseases?

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

Review 4.  Genetic and epigenetic influences on the loss of tolerance in autoimmunity.

Authors:  Peng Zhang; Qianjin Lu
Journal:  Cell Mol Immunol       Date:  2018-03-05       Impact factor: 11.530

Review 5.  Treatment options for juvenile-onset systemic lupus erythematosus.

Authors:  Luis Carreño; Francisco Javier López-Longo; Carlos Manuel González; Indalecio Monteagudo
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

6.  Organ and gestational age effects of maternal nutrient restriction on global methylation in fetal baboons.

Authors:  A Unterberger; M Szyf; P W Nathanielsz; Laura A Cox
Journal:  J Med Primatol       Date:  2009-08       Impact factor: 0.667

7.  Decreased DNA methyltransferase 3A and 3B mRNA expression in peripheral blood mononuclear cells and increased plasma SAH concentration in adult patients with idiopathic thrombocytopenic purpura.

Authors:  Jie Tao; Ming Yang; Zhong Chen; Ying Huang; Qinjun Zhao; Jianhui Xu; He Ren; Hui Zhao; Zhenping Chen; Qian Ren; Renchi Yang
Journal:  J Clin Immunol       Date:  2008-08-06       Impact factor: 8.317

Review 8.  Epigenetic therapeutics in autoimmune disease.

Authors:  Moshe Szyf
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

Review 9.  DNA methylation signatures for breast cancer classification and prognosis.

Authors:  Moshe Szyf
Journal:  Genome Med       Date:  2012-03-30       Impact factor: 11.117

10.  Prenatal synthetic glucocorticoid treatment changes DNA methylation states in male organ systems: multigenerational effects.

Authors:  Ariann Crudo; Sophie Petropoulos; Vasilis G Moisiadis; Majid Iqbal; Alisa Kostaki; Ziv Machnes; Moshe Szyf; Stephen G Matthews
Journal:  Endocrinology       Date:  2012-05-07       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.